Authors: WITJES JA CARIS CTM MUNGAN NA DEBRUYNE FMJ WITJES WPJ

Citation: Ja. Witjes et al., RESULTS OF A RANDOMIZED PHASE-III TRIAL OF SEQUENTIAL, INTRAVESICAL THERAPY WITH MITOMYCIN-C AND BACILLUS-CALMETTE-GUERIN VERSUS MITOMYCIN-C ALONE IN PATIENTS WITH SUPERFICIAL BLADDER-CANCER, The Journal of urology, 160(5), 1998, pp. 1668-1671

Authors: WITJES WPJ ROSIER PFWM CARIS CTM DEBRUYNE FMJ DELAROSETTE JJMCH

Citation: Wpj. Witjes et al., URODYNAMIC AND CLINICAL EFFECTS OF TERAZOSIN THERAPY IN SYMPTOMATIC PATIENTS WITH AND WITHOUT BLADDER OUTLET OBSTRUCTION - A STRATIFIED ANALYSIS, Urology, 49(2), 1997, pp. 197-205

Authors: WITJES WPJ ROSIER PFWM CARIS CTM DEBRUYNE FMJ DELAROSETTE JJMCH

Citation: Wpj. Witjes et al., URODYNAMIC AND CLINICAL EFFECTS OF TERAZOSIN THERAPY IN SYMPTOMATIC PATIENTS WITH AND WITHOUT BLADDER OUTLET OBSTRUCTION - A STRATIFIED ANALYSIS - REPLY, Urology, 49(2), 1997, pp. 206-206

Authors: WITJES WPJ DEWILDT MJAM ROSIER PFWM CARIS CTM DEBRUYNE FMJ DELAROSETTE JJMCH

Citation: Wpj. Witjes et al., VARIABILITY OF CLINICAL AND PRESSURE-FLOW STUDY VARIABLES AFTER 6 MONTHS OF WATCHFUL WAITING IN PATIENTS WITH LOWER URINARY-TRACT SYMPTOMS AND BENIGN PROSTATIC ENLARGEMENT, The Journal of urology, 156(3), 1996, pp. 1026-1034

Authors: VANGILSGIELEN RJM WITJES WPJ CARIS CTM DEBRUYNE FMJ WITJES JA OOSTERHOF GON

Citation: Rjm. Vangilsgielen et al., RISK-FACTORS IN CARCINOMA IN-SITU OF THE URINARY-BLADDER, Urology, 45(4), 1995, pp. 581-586